Free Daily Podcast Summary
Unblinded: A Clinical Trial Podcast: Daily Summaries Delivered
by Veeva
State of Digital Clinical Trials is a Veeva podcast hosted by Manny Vazquez, Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric?
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Apr 15, 202633 min
Deep Pockets, Short Arms: Is MedTech Ready for AI?
In this episode of Unblinded, host Manny Vazquez is joined by Leianne Ebert, Head of Data Operations at Alcon, and co-host John Acampado, Senior Director of Clinical Strategy for Veeva MedTech. Together, they explore the regulatory differences between pharma and medical device trials, data standards, and the industry’s digital maturity. Leianne and John also provide a reality check on AI readiness, debating the "deep pockets, short arms" mentality of the industry, and end with a call to action for systemic technology adoption.
- Mar 5, 202645 min
The Economics of Clinical Trial Outsourcing
Joel White, owner of Marketcap Consulting, together with Veeva’s Chris Kreitel, joins Manny to discuss why the next era of clinical trial outsourcing will be defined by technology integration and economic agility. They debate whether CROs are the ultimate masters of integrating tech, and the role of small biotechs as growth drivers in the market.
- Jan 29, 202634 min
A People-Focused Approach to a Risk-Based Future in Clinical Trials
In this episode, host Manny Vazquez is joined by Noeleen Turner, head of clinical data management at UCB, and Anna Hayes, senior director of clinical data management at Veramed. Using their breadth of experience and passion for a people-focused approach to clinical trial advancement, together they dive into hot topics like risk-based data management, the intricacies of change management in clinical data, and the growing importance of endpoint-driven design.
- Jan 15, 202627 min
ICH E6(R3): Shifting the Paradigm from Process to Purpose
In this episode, we pull back the curtain on the monumental effort required to reshape global clinical trial standards. Manny and guests Lisbeth Bregnhoj and Cheryl Grandinetti explore why ICH E6(R3) is the catalyst the industry has been waiting for. From the intense complexity of dialing in language across regional borders to the latest push for a truly risk-based approach to clinical trials, the discussion highlights: A shift in strategy: Why the industry is finally moving away from "one-size-fits-all" in favor of flexibility and high-level data governance Defining quality: Breaking down what Critical-to-Quality (CtQ) factors actually look like in practice and how to align that understanding between sponsors, service providers, and investigators The future of inspections: It’s not just a change for sponsors – regulators are also facing a major shift in how they harmonize inspection techniques in a risk-based world
- Dec 17, 202531 min
The Unstuck Industry: A New Equitable Model for Pharma
Brian Johnson, former head of R&D technology at Takeda, now consultant, shares his unique perspective on a topic that’s top-of-mind for many: how do you introduce new technologies and processes without alienating the people who need them most? He and Manny also tackle the critical issue of health equity, examining how technology can help diversify clinical trials and, in turn, create a more equitable future for all. Join us as we explore the business case for change and the crucial steps needed to unstick the industry from its current trajectory.
- Nov 6, 202538 min
Innovation from the Inside: How Sites Are Redefining Clinical Research
Manny is joined by co-host Denali Rose and MSKCC’s Joe Lengfellner, to discuss the shifting focus from a one-size-fits-all approach to redefine site centricity. They talk about how the role of a clinical trial coordinator is changing, the challenges of managing data and protocol amendments across different systems, and the promise of technologies like EHR-to-EDC to streamline workflows. They debate the potential of LLMs to revolutionize patient recruitment and widen access to clinical trials, addressing the critical issue of reaching more diverse patient populations.
- Oct 1, 202526 min
Patient vs. Process: Bridging the Gap for a Better Trial Experience
Join host Manny Vazquez as he sits down with Joyce Moore, leading voice in patient recruitment with over 25 years of experience in the industry, most recently at Allucent. In a field often focused on the logistics of data collection and study processes, Joyce offers a crucial perspective: seeing patients not as subjects, but as collaborators. She and Manny discuss the delicate balance of collecting essential data for clinical endpoints without overwhelming patients. Joyce also highlights the critical role of technology in enhancing the patient experience and the importance of keeping participants informed about their progress and the purpose behind the data being collected. Recorded at R&D and Quality Summit 2025 in Madrid.
- Sep 15, 202533 min
Biggest Risks (and Possible Rewards) of AI in Clinical Data
Are we any closer to working out the human-machine relationship needed to embed AI in clinical development? To discuss this and all things automation, Veeva’s Chief Technology Officer Drew Garty joins host Manny Vazquez as he kicks off the new season with two innovators in the industry: Doug Bain, founder and consulting partner at Clinflo, and Robert Bergann, clinical digital innovation leader at Bayer. Recorded at R&D and Quality Summit 2025 in Madrid.
About Unblinded: A Clinical Trial Podcast
State of Digital Clinical Trials is a Veeva podcast hosted by Manny Vazquez, Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric?
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Unblinded: A Clinical Trial Podcast in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Unblinded: A Clinical Trial Podcast daily summary?
It's a free AI-powered email that summarizes new episodes of Unblinded: A Clinical Trial Podcast as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Unblinded: A Clinical Trial Podcast podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Unblinded: A Clinical Trial Podcast product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Veeva.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does Unblinded: A Clinical Trial Podcast release new episodes?
Unblinded: A Clinical Trial Podcast publishes monthly. Our AI generates a summary within hours of each new episode.
What topics does Unblinded: A Clinical Trial Podcast cover?
Unblinded: A Clinical Trial Podcast covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Unblinded: A Clinical Trial Podcast summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.